Yaz Lawsuit to Include Gallbladder Disease

Many women have suffered from life changing problems from Yaz gallbladder side effects but did not know that their birth control pill may have caused gallstones and other complications. Talia K. Weiss’ Yaz lawsuit has alleged that developed gallbladder disease as a result of taking the birth control pill. Her Yaz lawsuit, filed in Seminole County in October 12, 2011, was recently transferred to the District Court for the Middle District of Florida on January 17, 2012. Weiss’ Yaz lawyers have alleged that the drugmaker, Bayer Corporation, did not label the product with a strong enough warning of its side effects. Weiss continued to take the medication until 2010 when she became aware of the severe injuries associated with her gallbladder disease.

Gallbladder disease is a dangerous Yasmin side effect reported by women using this fourth-generation birth control. Women are twice as likely as men to develop gallstones. The hormones in birth control pills may increase cholesterol levels in bile and decrease gallbladder movement, which can create gallstones which can cause serious problems if they become trapped in the bile ducts. Gallstone symptoms can be similar to many other conditions including ulcers, heart attack and irritable bowel syndrome. Not all gallstones show up on regular X-rays. Ultrasound can most often show whether gallstones are present. A HIDA scan, which uses an injection of radioactive dye, shows whether the gallbladder is blocked and inflamed and therefore the cause of pain. It can also show if the gall bladder is working properly.

Yaz and gallbladder problems are affecting women who had previously not had any problems with gallstones. Some women who suffered from frequent gallstones or inflammation recurs have had to undergo gallbladder removal surgery. Following surgery, women who were diagnosed with gallbladder disease are forced to deal with gallbladder removal side effects which include dietary changes and avoiding certain fats in foods. Weiss’ Yaz lawsuit seeks damages to compensate for medical bills, lost wages, pain and suffering and a shortened life span. Her Lawsuit alleges that if the Yaz side effects had been made clear, she never would have taken the drug.

Yaz and Yasmin Have Few Differences Despite Differences

Both Yasmin and Yaz are produced by Bayer healthcare and are currently known as fourth generation birth control pills. Unfortunately, there has been a lot of discussion on the side effects produced by both the medications. While Yasmin has been found to produce side effects like Yaz gallbladder disease, blood clots in the legs etc, the side effects from Yaz have been reported to be more severe in nature. Yaz lawsuits, Yasmin lawsuits and Ocella lawsuits are being reviewed throughout the United States for women who have suffered serious and potentially life-threatening blood clots, including a deep vein thrombosis (Yaz DVT), which forms in the deep veins of the legs, pelvis or arms.

A DVT or deep vein thrombosis is a type of blood clot that usually occurs in the legs or deep veins of the pelvis.  While it is possible to have a DVT with minimal symptoms, they usually cause extreme pain and swelling in the affected limb.  If the Yaz Deep Vein Thrombosis dislodges, it could travel to other parts of the body and cause a pulmonary emolism, heart attack or stroke.According to an August 2009 study published in the British Medical Journal,

Women Seek Yaz Damages from Bayer for Misleading Advertisements

Every Yaz birth control suits involve allegations that Bayer failed to properly research their birth control pills or adequately warn about the increased risk of serious and potentially life-threatening injuries from the birth control pills containing drospirenone, such as a Yaz Stroke, heart attack, Yaz pulmonary embolism, deep vein thrombosis or gallbladder disease.Yaz and Yasmin were both brought to market by Berlex Labs. Yaz came on the market in 2001, and Yasmin followed five years later. In 2006, Berlex was acquired by Bayer. Backed by big marketing campaigns, it wasn’t long before both drugs were racking up big sales for Bayer. Annual sales of Yaz reached $361 last year. Annual sales of Yasmin peaked in 2008 at $329 million, but have declined somewhat since then.

According to lawsuits filed against Bayer, the makers of Yaz and Yasmin knew or should have known about the risk of Yaz gallbladder disease complications associated with their birth control pill, yet failed to adequately warn about the problems.

Yasmin Gallbladder Disease Has Florida Women Suing For Damages

Alethia M. Lopez and Jessica A. Endick of Tampa, Florida added their lawsuits to the growing case against Bayer’s birthcontrol pills, Yaz and Yasmin. On October 3rd, both women filed suits seeking compensatory damages of $75,000 to pay for gallbladder removal surgery as well as punitive damages. In addition to Yaz gallbladder disease, in August of 2009, The British Medical Journal published the results of two independent studies conducted on women in Denmark and The Netherlands. Both of these studies reached the conclusion that women taking the progestin drospirenone found in Yaz and Yasmin were at a higher risk for venous Yaz blood clots.

Over 50 deaths have been reported to the FDA in women taking oral contraceptives containing drosprienone such as Yaz, Yasmin or Ocella from heart problems, heart attacks, blood clots in the heart and lungs, and Yaz Stroke.  In addition, the Agency has received hundreds of reports of non-fatal side effects from these conditions.

Plaintiffs Questioning Potential Settlement Amounts in Yaz Lawsuits

As of February 2011, Bayer faced nearly 7,000 lawsuits against their Yaz and Yasmin birth control pills and the number of new claims is continuing to grow. It is anticipated that to resolve the litigation, the pharmaceutical company will ultimately need to reach Yaz settlements and Yasmin settlements with up to 25,000 women.Currently the Yasmin and Yaz lawsuit have been centralized for pretrial proceedings in the federal court system as well as several states. In federal court, all cases filed throughout the country are being handled out of the U.S. District Court for the Southern District of Illinois for coordinated management during discovery, the early bellwether trials and any preliminary attempts to negotiate settlement offers. Similar centralized management for the cases has been put in place for state court cases filed in New Jersey and Pennsylvania.

All of the cases involve similar allegations that Bayer failed to adequately warn about the risk of serious and potentially life-threatening side effects of Yaz and Yasmin birth control, such as a stroke pulmonary embolism, deep vein thrombosis or Yaz gallbladder disease. Plaintiffs’ attorneys recently asked Judge Herndon to consolidate several cases for the second and third trials,

Woman Files Northern California Yaz Lawsuit

A growing number of Yasmin lawsuits and Yaz class action lawsuit have been filed over alleged side effects of the birth control pills, which may increase the risk of heart attack, stroke, deep vein thrombosis, (DVT), pulmonary embolysm (PE), Yaz gallbladder disease, death and other serious injuries. Another lawsuit has been filed against Bayer Pharmaceuticals over Yasmin injuries. Louise Thanos says she took Yasmin, which is manufactured by Bayer Pharmaceuticals, from November 20007 to November 2009, and alleges she suffered from organ failure as a result of the pills. Thanos also alleges that, in March 2008, she suffered from gallbladder failure, according to the lawsuit filed in San Mateo County Superior Court.

Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the U.S. Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyperkalemia, atrial fibrillation, tachycardia, myocardial infarction, stroke, blood clots, Yaz pulmonary embolism, and sudden death.The drug makers had sole access to facts concerning the potential Yaz problems, and ignored the correlation between their drug and potentially life-threatening side effects. 

Yaz Pulmonary Embolism Lawsuits on the Rise

Yaz birth control, despite the many controversies surrounding it, continues to be one of the most popular forms of hormonal birth control used across the country. Women continue to experience severe cardiovascular Yaz side effects from the drospirenone-based fourth generation birth control pill, but more and more people – especially teenagers and young women – continue to use the potentially dangerous medication on a regular basis, despite the growing number of Yaz lawsuit directed towards its drugmaker, Bayer Pharmaceuticals.

Pulmonary embolism, deep vein thrombosis, and cor pulmonale are all conditions that can develop from blood clots, depending where they are located in the body. Yaz Deep Vein Thrombosis occurs when a blood clot forms in a vein deep in the body, usually in the leg. Blood clots here can travel through the body to block an artery to the lung and potentially cause pulmonary embolism.

Yaz Pulmonary Embolism Among First on Trial

Bellwether trials in the ongoing Yaz and Yasmin litigation cases are slowly making their way towards their first day, and among the first cases on trial will involve the deadly Yaz pulmonary embolism. A pulmonary embolism takes place when a Yaz blood clots makes its way to one of the arteries in the lung. One in three people who experience pulmonary embolism do not survive it, and as such it is one of the deadliest killers in the country. The Food and Drug Administration is expected to issue a report on Yaz pulmonary embolism as associated with Yaz and Yasmin by the end of the year.

Even young women are at risk for severe Yaz side effects, and the birth control remains a popular one for teenage girls and young adults. Although there is some risk of blood clots with any hormonal birth control medication,

Yaz Pulmonary Embolism Accusers Filing

Bayer, the manufacturer of popular fourth-generation birth control pill Yaz, are facing a slew of lawsuits that have been plaguing them for years already. Yaz lawsuit allege that Yaz has caused a number of patients serious pain, emotional trauma, and other complications that could last for the rest of their lives. Yaz has been linked to a number of serious medical conditions, some of them fatal, many of which relate in some way to blood clots forming and possibly breaking off from the vein in which they were formed. 

Yaz pulmonary embolism is one of the most serious conditions represented by Yaz lawsuits—and one of the most common. Other side effects alleged in lawsuits include heart arrhythmia, Yaz Stroke, blood clots like deep vein thrombosis, and Yaz gallbladder disease. It occurs when a blood clot forms in an extremity such as the leg, then breaks off and travels through the bloodstream to block one of the main arteries in the lung.

Yaz Stroke Hurts the Healthy

Even otherwise healthy women can find themselves experiencing blood clots, stroke, heart arrhythmia, gallbladder disease, and pulmonary embolism—especially if they take the popular fourth-generation birth control marketed as Yaz or Yasmin. Both of these medications are based around a synthetic hormone called drospirenone, which science thinks could be the culprit behind the raised risk of Yaz blood clots problems and other issues with the birth control pill. And there are some issues—Yaz users are up to six times more likely to experience problems with blood clots and other Yaz side effects than women who take other forms of hormonal birth control. This is while taking into account the fact that all hormonal birth control, whether it be in pill, patch, or ring form, comes with some heightened risk of blood clots.

Almost 6,000 cases have been filed across the country regarding serious side effects such as Yaz Stroke and pulmonary embolism. These side effects can be fatal—and have proven to be in a number of cases.

Judge In Yaz MDL Announces Hopes For Settlements to Occur

In October 2010, Judge Herndon implemented a process that calls for a handful of cases to be prepared for a series of three early trials, known as bellwether cases. The first trial will involve a Yaz pulmonary embolism. The second trial will involve a gallbladder injury from Yaz and the third trial will involve a venous thromboembolism (VTE), such as a deep vein thrombosis (DVT). Currently the Yasmin and Yaz lawsuits have been centralized for pretrial proceedings in the federal court system as well as several states. In federal court, all cases filed throughout the country are being handled out of the U.S. District Court for the Southern District

Yaz Gallbladder Disease Highest Risk Among Birth Controls

In addition to the potential risk of serious and potentially life-threatening Yaz blood clots, many otherwise healthy young women who have used the birth control pill Yaz or Yasmin have experienced painful gallbladder problems that could ultimately require surgery for gallbladder removal. The FDA has warned the manufacturers of Yaz (sometimes spelled as Yas) and Yasmin (sometimes spelled as Yazmin) at least four times for improper marketing and manufacturing techniques, starting as far back as July 2003, and continuing through 2009.
Yasmin and Yaz are birth control pills manufactured by Bayer Healthcare. The generic form of these drugs, Ocella, is a brand marketed and distributed by Teva Pharmaceuticals. Yasmin was approved by the FDA in 2001, Yaz in 2006, and Ocella in 2008. The Yaz group of drugs contains a compound created by Bayer called drospirenone, which is a “fourth generation” progestin. Drospirenone is believed to elevate the levels of potassium in the blood stream. Elevated levels of potassium in the blood can lead to a condition known as hyperkalemia, which can cause heart rhythm disturbances. Before the introduction of Yasmin, no other birth control pill was marketed in the United States with drospirenone, which is unlike other progestins available. It is a diuretic, which creates unique risks with Yaz and Yasmin and could lead to serious gall bladder problems like gallbladder disease.
In 2009, Bayer was forced to run a $20 million corrective advertising campaign to address problems with Yaz advertisements that stressed the potential benefits in treating acne and symptoms of PMS, while minimizing the potential risk of blood clots. The ads were found to be in violation of a 2007 agreement Bayer made with the FDA after earlier deceptive advertising campaigns. For the next several years, Bayer is now required to submit any future Yaz advertisements in the United States to the FDA for approval before they are aired. Bayer currently faces about 7,500 Yaz lawsuits and Yasmin lawsuits, which allege that Bayer has failed to adequately warn about the increased risk of health problems associated with the birth control pills.

Yasmin Blood Clots – Same as Yaz

Yaz and Yasmin are both drospirenone-based oral contraceptives that are manufactured by Bayer Pharmaceuticals, a pharmaceuticals giant that is one of the largest in the nation. Many patients wonder what the difference is between the two medications, or whether the extremely publicized Yaz side effects associated with the birth control are also linked to Yasmin. Consumers want to be able to make an educated decision when it comes to their medical treatments and the drugs they take, and it is natural for patients to wonder whether they are safe.

Yaz Side Effects Are Even More Terrifying Due To Young Deaths

As of February 2011, Bayer faced nearly 7,000 Yaz lawsuits against their birth control pills and the number of new claims is continuing to grow. It is anticipated that to resolve the litigation, the pharmaceutical company will ultimately need to reach Yaz settlements and Yasmin settlements with up to 25,000 women. The injury lawsuits for Yaz and Yasmin involve claims that Bayer failed to adequately research their popular birth control pills and warn about the increased risk of serious and potentially life threatening side effects of Yasmin and Yaz. Settlement compensation is being pursued by women who have suffered injuries such as: heart attack or stroke, pulmonary embolism from, deep vein thrombosis and gallbladder problems. Bayer is currently indicating that they intend to fight the cases and do not have any plans to settle Yaz or Yasmin lawsuits.

Yaz Side Effects Now Include Pancreatitis, According to FDA

The Food and Drug Administration has issued an order to all manufacturers of certain birth control pills to include pancreatitis on warning labels of birth control pills that contain the hormones drospirenone and estrogen. Such oral contraceptives, including the controversial Yaz and Yasmin brands, have been linked to pancreatitis in the past, but it is now clear that there is a definitive link as the disease is now an “official” side effect. The Food and Drug Administration’s order could cause legal trouble for many drugmakers. Individuals are contacting Yaz lawyers to discuss how to pursue legal action.

Yaz Lawyers Inform Clients of Differences in Side Effects

Many patients who have experienced Yaz side effects, including deep vein thrombosis and pulmonary embolism, are aware of the complications they have experienced but are unaware of either what exactly those side effects indicate and what the difference is between the two popular birth control medications.
Both once-daily birth control pills are based on the hormone drospirenone, but Yaz has a higher dose of estrogen than Yasmin does. In addition, the Food and Drug Administration has approved Yaz for purposes other than preventing pregnancy, including treatment of mild to moderate acne and premenstrual dysphoric disorder, a more severe form of PMS. Yasmin is approved only for preventing pregnancy. Both come with the same set of side effects, however.

Yasmin DVT Put on Trial

Although trials of Yaz and Yasmin lawsuits are not set to begin until early next year, the drospirenone-based birth control pills are still a hot topic in the medical community. Many experts are arguing that, since many products are available that do the same job at a fraction of the risk, there is no value in keeping the controversial products on the market. Many patients have filed lawsuits against drugmaker Bayer, complaining of side effects they have suffered after taking the once-daily pill. The first bellwether trial involves a pulmonary embolism case. Pulmonary embolism is one of the most severe side effects of Yaz and Yasmin and occurs when a blood clot makes its way into a patient’s lung.

Despite Safety Concerns, Generic Forms of Yaz Birth Control Go Forward

Although Bayer has continued to maintain that there is no increased risk of blood clots fromYasmin and Yaz side effects, the FDA and European drug regulators forced the drug maker to update the blood clot warnings on Yaz and Yasmin labels last year. The FDA finally announced this week that they are evaluating the risk of blood clots from Yaz, Yasmin and Beyaz birth control, which some studies have shown to be 2 to 3 times greater than the risk associated with other birth control pills. The safety review was initiated based on two published studies that reported there is a greater risk of venous thromboembolism (VTE) among women taking Yaz, Yasmin or other drospirenone birth control pills.

Blood Clots and Hyperkalemia Linked to Yaz Birth Control

Growing concerns over the risk of Yaz blood clots from side effects of drospirenone, the active ingredient in Yaz and Yasmin birth control, has led Canadian health officials to launch an investigation, just one week after U.S. regulators launched a similar safety review of the popular pills. Notice of the safety review into a possible risk of blood clots with birth control pills containing drospirenone was released in the United States by the FDA on May 31, providing additional information for women taking the medications. The safety review was initiated based on two published studies that reported there is a greater risk of venous thromboembolism (VTE) among women taking Yaz, Yasmin or other drospirenone birth control pills. The risk has been reported to be up to 2 to 3 times greater than the risk associated with levonorgestrel birth control pills.

Yasmin DVT Put on Trial

Although trials of Yasmin and Yaz lawsuits are not set to begin until early next year, the drospirenone-based birth control pills are still a hot topic in the medical community. Many experts are arguing that, since many products are available that do the same job at a fraction of the risk, there is no value in keeping the controversial products on the market. Many patients have filed lawsuits against drugmaker Bayer, complaining of side effects they have suffered after taking the once-daily pill. The first bellwether trial involves a pulmonary embolism case. Pulmonary embolism is one of the most severe side effects of Yaz and Yasmin and occurs when a blood clot makes its way into a patient’s lung.